Sagefield Capital »

Peregrine Pharmaceuticals shares owned by Sagefield Capital

Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by Sagefield Capital from 13F filings

Historical chart of Sagefield Capital investment in Peregrine Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Peregrine Pharmaceuticals held by Sagefield Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Peregrine Pharmaceuticals by Sagefield Capital

Quarter filed Position value Share count Share price at filing
2024-12-31 $3.1M 248k 12.35